Earnings History Data for Salarius Pharmaceuticals (SLRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Salarius Pharmaceuticals

Salarius Pharmaceuticals Inc. is a clinical-stage oncology company. It develops therapies for the treatment of cancers. The company's lead candidate is Seclidemstat, which is in clinical development for the treatment of Ewing sarcoma, as well as advanced solid tumors, including prostate, breast, and ovarian cancers. Salarius Pharmaceuticals Inc., formerly known as Flex Pharma Inc., is based in Houston, Texas.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
22-03-2024	AH		SLRX	Salarius Pharmaceuticals	2.00	-0.22	-1.01	0.00	Salarius Pharmaceuticals GAAP EPS of -$3.84 [3/22/2024 4:17 PM]	0.5474	-0.07 (-11.71%)	0.71	0.09 (14.52%)	0.50 - 2.68	1,406,220	150,000	1,798,933

10-08-2023	AH		SLRX	Salarius Pharmaceuticals	3.00	-1.43	-1.26	0.00	Salarius Pharmaceuticals GAAP EPS of -$1.43 [8/10/2023 5:29 PM]	0.65	-0.04 (-5.62%)	0.71	0.02 (2.61%)	0.61 - 7.20	65,617	60,000	657
Salarius Pharmaceuticals GAAP EPS of -$1.43 [8/10/2023 5:29 PM] Salarius Pharmaceuticals exploring strategic alternatives; 50% workforce layoffs [8/10/2023 12:20 PM]
27-03-2023	PM		SLRX	Salarius Pharmaceuticals	5.00	-2.83	-2.07	0.00		2.07	-0.04 (-1.90%)	0.0	0.0 (0.00%)	1.07 - 11.10	3,981	10,000	0

12-05-2022	AH	4:05 PM ET (May 12)	SLRX	Salarius Pharmaceuticals, Inc.	10.79	-0.13	0.00	-0.06	Salarius Pharmaceuticals GAAP EPS of -$0.13 misses by $0.04 [5/12/2022 4:13 PM]	0.1829	-0.04 (-17.61%)	0.18	-0.04 (-17.97%)	0.16 - 1.51	2,497,312	1,980,000	562,489
Salarius Pharmaceuticals GAAP EPS of -$0.13 misses by $0.04 [5/12/2022 4:13 PM] Salarius Pharmaceuticals Completes SP-3164 Pre-Investigational New Drug Meeting Process with the U.S. Food and Drug Administration [May-11-22 04:05PM] Salarius Pharmaceuticals Reports Business Highlights with First Quarter 2022 Financial Results [May-12-22 04:05PM]
10-03-2022	AH	4:05 PM ET (Mar 10)	SLRX	Salarius Pharmaceuticals, Inc.	17.36	-0.09	-0.10	-0.10	Salarius Pharmaceuticals GAAP EPS of -$0.09 misses by $0.01 [3/10/2022 4:21 PM]	0.3690	-0.13 (-26.20%)	0.45	-0.05 (-10.00%)	0.33 - 1.66	1,466,880	660,000	248,258
Salarius Pharmaceuticals GAAP EPS of -$0.09 misses by $0.01 [3/10/2022 4:21 PM] Salarius Pharmaceuticals Reports Business Highlights with Fourth Quarter and Full-Year 2021 Financial Results [Mar-10-22 04:05PM]
04-11-2021	AH	4:05 PM ET (Nov 4)	SLRX	Salarius Pharmaceuticals, Inc.	37.86	-0.08	-0.09	-0.10	Salarius Pharmaceuticals EPS misses by $0.02 [11/4/2021 4:37 PM]	0.7572	-0.08 (-9.33%)	0.84	0.0 (0.57%)	0.64 - 3.50	1,424,866	570,000	3,115
Salarius Pharmaceuticals EPS misses by $0.02 [11/4/2021 4:37 PM] Salarius Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress [Nov-04-21 04:05PM]
05-08-2021	PM	8:00 AM ET (Aug 5)	SLRX	Salarius Pharmaceuticals, Inc.	36.71	-0.07	-0.06	-0.13	Salarius Pharmaceuticals EPS misses by $0.01, misses on revenue [8/5/2021 7:39 AM]	0.8027	0.01 (0.97%)	0.82	0.03 (3.14%)	0.63 - 3.50	428,948	390,000	8,880
Salarius Pharmaceuticals EPS misses by $0.01, misses on revenue [8/5/2021 7:39 AM] Salarius Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress [Aug-05-21 07:32AM]
12-05-2021	AH	4:05 PM ET (May 12)	SLRX	Salarius Pharmaceuticals, Inc.	54.13	-0.06	0.00	-0.22	Salarius Pharmaceuticals EPS in-line, misses on revenue [5/12/2021 4:25 PM]	1.22	0.07 (6.09%)	1.15	0.0 (0.00%)	0.63 - 3.50	1,348,322	710,000	19,685
Salarius Pharmaceuticals EPS in-line, misses on revenue [5/12/2021 4:25 PM] Salarius Pharmaceuticals Inc to Host Earnings Call [May-12-21 02:45PM] Salarius Pharmaceuticals Reports First Quarter Financial Results with Business Highlights [May-12-21 04:05PM]
18-03-2021	AH	4:05 PM ET (Mar 18)	SLRX	Salarius Pharmaceuticals, Inc.	72.35	-0.10	0.00	0.00	Salarius Pharmaceuticals EPS beats by $0.01, revenue in-line [3/18/2021 4:12 PM]	1.55	0.05 (3.26%)	1.50	0.0 (0.00%)	0.56 - 3.50	1,706,499	1,530,000	14,447
Salarius Pharmaceuticals EPS beats by $0.01, revenue in-line [3/18/2021 4:12 PM] Salarius Pharmaceuticals Inc to Host Earnings Call [Mar-18-21 02:30PM] Salarius Pharmaceuticals Reports Business Highlights with Fourth Quarter and Full-Year 2020 Financial Results [Mar-18-21 04:05PM]
11-11-2020	AH	4:05 PM ET (Nov 11)	SLRX	Salarius Pharmaceuticals, Inc.	14.07	-0.10	0.00	-1.04	Salarius Pharmaceuticals EPS in-line, beats on revenue [11/11/2020 4:10 PM]	0.7377	-0.03 (-3.42%)	0.78	0.02 (2.12%)	0.56 - 4.98	329,755	118,267	11,704

12-08-2020	AH	4:05 PM ET (Aug 12)	SLRX	Salarius Pharmaceuticals, Inc.	22.93	-0.13	0.00	2.00	Salarius Pharmaceuticals EPS beats by $0.04, beats on revenue [8/12/2020 4:14 PM]	1.03	-0.04 (-3.74%)	1.10	0.03 (2.80%)	0.56 - 13.50	95,650	425,817	5,159

14-05-2020	AH		SLRX	Salarius Pharmaceuticals, Inc.	12.03	-0.22	0.00	3.00	Salarius Pharmaceuticals EPS beats by $0.22, misses on revenue [5/14/2020 4:12 PM]	0.8501	0.01 (1.23%)	0.86	0.01 (1.16%)	0.56 - 24.45	324,126	243,980	1,539